VS

Vikas Sharma

Active Director Director DIN 09273640
DIN 09273640 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Vikas Sharma

Data last updated:

Vikas Sharma is a Director at Denken Biotech Private Limited (since 2021). The company operates in Chemicals. Denken Biotech Private Limited reported revenue of ₹5.90 Cr (FY 2024).

DIN 09273640
Primary Designation Director
Industry Chemicals
First Appointment 09 Aug 2021
Oldest Company Age 5 yrs
Largest company Denken Biotech Private Limited · ₹5.90 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Denken Biotech Private Limited U24239HR2021PTC096888
Director09 Aug 20212021₹5.90 Cr (FY 2024)Active

Board colleagues of Vikas Sharma

NameDINCompanyDesignation
Deepak Sharma09273641Denken Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Denken Biotech Private Limited
Premium access

Shareholding and investment profile for Vikas Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Sharma

Vikas Sharma currently holds 1 directorship: Denken Biotech Private Limited (Director, since 09 Aug 2021, revenue ₹5.90 Cr (FY 2024)).

Vikas Sharma was first appointed on 09 Aug 2021 as Director at Denken Biotech Private Limited.

The current boards of Vikas Sharma's companies include Deepak Sharma (Denken Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available